Biphenyl Backbone-Based (Bis)Urea and (Bis)Thiourea Derivatives as Antimicrobial and Antioxidant Agents and Evaluation of Docking Studies and ADME Properties

References

• J. Davies and D. Davies, “Origins and Evolution of Antibiotic Resistance,” Microbiology and Molecular Biology Reviews 74, no. 3 (2010): 417–33.
   PubMed Web of Science ®Google Scholar
• Y. Niu, R. E. Wang, H. Wu, and J. Cai, “Recent Development of Small Antimicrobial Peptidomimetics,” Future Medicinal Chemistry 4, no. 14 (2012): 1853–62.
   PubMed Web of Science ®Google Scholar
• L. L. Silver, “Challenges of Antibacterial Discovery,” Clinical Microbiology Reviews 24, no. 1 (2011): 71–109.
   PubMed Web of Science ®Google Scholar
• A. K. Marr, W. J. Gooderham, and R. E. Hancock, “Antibacterial Peptides for Therapeutic Use: Obstacles and Realistic Outlook,” Current Opinion in Pharmacology 6, no. 5 (2006): 468–72.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO), 2014. “Antimicrobial Resistance: Global Report on Surveillance. WHO Rep,”
   Google Scholar
• D. Awasthi, K. Kumar, and I. Ojima, “Therapeutic Potential of FtsZ Inhibition: A Patent Perspective,” Expert Opinion on Therapeutic Patents 21, no. 5 (2011): 657–79.
   PubMed Web of Science ®Google Scholar
• Y. T. Tan, D. J. Tillett, and I. A. McKay, “Molecular Strategies for Overcoming Antibiotic Resistance in Bacteria,” Molecular Medicine Today 6, no. 8 (2000): 309–14.
   PubMedGoogle Scholar
• A. I. Hidron, A. N. Schuetz, F. S. Nolte, C. V. Gould, and M. K. Osborn, “Daptomycin Resistance in Enterococcus faecalis Prosthetic Valve Endocarditis,” The Journal of Antimicrobial Chemotherapy 61, no. 6 (2008): 1394–6.
   PubMed Web of Science ®Google Scholar
• A. H. Mutnick, V. Enne, and R. N. Jones, “Linezolid Resistance since 2001: SENTRY Antimicrobial Surveillance Program,” Annals of Pharmacotherapy 37, no. 6 (2003): 769–74.
   PubMed Web of Science ®Google Scholar
• C. J. Thomson, E. Power, H. Ruebsamen-Waigmann, and H. Labischinski, “Antibacterial Research and Development in the 21st Century – An Industry Perspective of the Challenges,” Current Opinion in Microbiology 7, no. 5 (2004): 445–50.
   PubMed Web of Science ®Google Scholar
• Z. J. Jain, P. S. Gide, and R. S. Kankate, “Biphenyls and Their Derivatives as Synthetically and Pharmacologically Important Aromatic Structural Moieties,” Arabian Journal of Chemistry 10 (2017): S2051–S2066.
   Web of Science ®Google Scholar
• M. Sadowska, E. Miller, S. Wysocki, G. M. Rodríguez-Muniz, A. M. Costero, and B. Wandelt, “Biphenyl-Type Sensing System in the Proton-Rich Environment by Fluorescence and Quantum-Chemical Calculations,” Journal of Luminescence 130, no. 6 (2010): 1085–91.
   Web of Science ®Google Scholar
• A. Mazzanti, L. Lunazzi, M. Minzoni, and J. E. Anderson, “Rotation in Biphenyls with a Single Ortho-Substituent,” The Journal of Organic Chemistry 71, no. 15 (2006): 5474–81.
   PubMed Web of Science ®Google Scholar
• T. Morimoto, K. Yoshikawa, M. Murata, N. Yamamoto, and K. Achiwa, “Preparation of Axially Chiral Biphenyl Diphosphine Ligands and Their Application in Asymmetric Dehydrogenation,” Chemical & Pharmaceutical Bulletin 52, no. 12 (2004): 1445–50.
   PubMed Web of Science ®Google Scholar
• I. Tabushi, K. Yamamura, and T. Nabeshima, “Characterization of Regiospecific AC- and AD-Disulfonate Capping of β-Cyclodextrin. capping as an Efficient Production Technique,” Journal of the American Chemical Society 106, no. 18 (1984): 5267–70.
   Web of Science ®Google Scholar
• B. Volker, M. Feigel, and M. Bremer, “2’-Aminomethylbiphenyl-2-Carboxylic Acid as a Component of a Cyclopeptide; Crystal Structure and Conformation in Solution,” Angewandte Chemie International Edition in English 28, no. 4 (1989): 486–8.
   Web of Science ®Google Scholar
• D. Hohnholz, K. H. Schweikart, L. R. Subramanian, A. Wedel, W. Wischert, and M. Hanack, “Synthesis and Studies on Luminescent Biphenyl Compounds,” Synthetic Metals 110, no. 2 (2000): 141–52.
   Web of Science ®Google Scholar
• M. P. Johansson, and J. Olsen, “Torsional Barriers and Equilibrium Angle of Biphenyl: reconciling Theory with Experiment,” Journal of Chemical Theory and Computation 4, no. 9 (2008): 1460–71.
   PubMed Web of Science ®Google Scholar
• H. Aldemir, R. Richarz, and T. A. M. Gulder, “The Biocatalytic Repertoire of Natural Biaryl Formation,” Angewandte Chemie 53, no. 32 (2014): 8286–93.
   Google Scholar
• G. Bringmann, T. Gulder, T. A. M. Gulder, and M. Breuning, “Atroposelective Total Synthesis of Axially Chiral Biaryl Natural Products,” Chemical Reviews 111, no. 2 (2011): 563–639.
   PubMed Web of Science ®Google Scholar
• A. Isnansetyo, and Y. Kamei, “Anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Activity of MC21-B, an Antibacterial Compound Produced by the Marine Bacterium Pseudoalteromonas phenolica O-BC30T,” International Journal of Antimicrobial Agents 34, no. 2 (2009): 131–5.
   PubMed Web of Science ®Google Scholar
• H. Rahman, B. Austin, W. J. Mitchell, P. C. Morris, D. J. Jamieson, D. R. Adams, A. M. Spragg, and M. Schweizer, “Novel anti-Infective Compounds from Marine Bacteria,” Marine Drugs 8, no. 3 (2010): 498–518.
   PubMed Web of Science ®Google Scholar
• C. C. Chang, G. O. Morton, J. C. James, M. M. Siegel, N. A. Kuck, R. T. Testa, and D. B. Borders, “LL-AF283 Antibiotics, Cyclic Biphenyl Peptides,” The Journal of Antibiotics 44, no. 6 (1991): 674–7.
   PubMed Web of Science ®Google Scholar
• I. Uchida, N. Shigematsu, M. Ezaki, M. Hashimoto, H. Aoki, and H. Imanaka, “Biphenomycin a & B, Novel Peptide Antibiotics II. Structural Elucidation of Biphenomyclns a & B,” The Journal of Antibiotics 38, no. 11 (1985): 1462–8.
   PubMed Web of Science ®Google Scholar
• P. J. Hajduk, M. Bures, J. Praestgaard, and S. W. Fesik, “Privileged Molecules for Protein Binding Identified from NMR-Based Screening,” Journal of Medicinal Chemistry 43, no. 18 (2000): 3443–7.
   PubMed Web of Science ®Google Scholar
• A. Cabrera, L. Cox, P. Velarde, W. C. Koskinen, and J. Cornejo, “Fate of Diuron and Terbuthylazine in Soils Amended with Two-Phase Olive Oil Mill Waste,” Journal of Agricultural and Food Chemistry 55, no. 12 (2007): 4828–34.
   PubMed Web of Science ®Google Scholar
• F. Fournet, C. Sannier, and N. Monteny, “Effects of the Insect Growth Regulators OMS 2017 and Diflubenzuron on the Reproductive Potential of Aedes aegypti,” Journal of the American Mosquito Control Association 9, no. 4 (1993): 426–30.
   PubMed Web of Science ®Google Scholar
• T. K. Venkatachalam, C. Mao, and F. M. Uckun, “Effect of Stereochemistry on the Anti-HIV Activity of Chiral Thiourea Compounds,” Bioorganic & Medicinal Chemistry 12, no. 15 (2004): 4275–84.
   PubMed Web of Science ®Google Scholar
• S. Saeed, N. Rashid, P. G. Jones, M. Ali, and R. Hussain, “Synthesis, Characterization and Biological Evaluation of Some Thiourea Derivatives Bearing Benzothiazole Moiety as Potential Antimicrobial and Anticancer Agents,” European Journal of Medicinal Chemistry 45, no. 4 (2010): 1323–31.
   PubMed Web of Science ®Google Scholar
• M. Eweis, S. S. Elkholy, and M. Z. Elsabee, “Antifungal Efficacy of Chitosan and Its Thiourea Derivatives upon the Growth of Some Sugar-Beet Pathogens,” International Journal of Biological Macromolecules 38, no. 1 (2006): 1–8.
   PubMed Web of Science ®Google Scholar
• S. K. Kashaw, V. Kashaw, P. Mishra, N. K. Jain, and J. P. Stables, “Synthesis, Anticonvulsant and CNS Depressant Activity of Some New Bioactive 1-(4-Substituted-Phenyl)-3-(4-Oxo-2-Phenyl/Ethyl-4H-Quinazolin-3-yl)-Urea,” European Journal of Medicinal Chemistry 44, no. 11 (2009): 4335–43.
   PubMed Web of Science ®Google Scholar
• G. P. Suresha, R. Suhas, W. Kapfo, and D. Channe Gowda, “Urea/Thiourea Derivatives of Quinazolinone-Lysine Conjugates: synthesis and Structure-Activity Relationships of a New Series of Antimicrobials,” European Journal of Medicinal Chemistry 46, no. 6 (2011): 2530–40.
   PubMed Web of Science ®Google Scholar
• A. N. A. Halim, and Z. Ngaini, “Synthesis and Bacteriostatic Activities of Bis(Thiourea) Derivatives with Variable Chain Length,” Journal of Chemistry 2016 (2016): 1–7.
   Web of Science ®Google Scholar
• B. K. Verlinden, M. De Beer, B. Pachaiyappan, E. Besaans, W. A. Andayi, J. Reader, J. Niemand, R. Van Biljon, K. Guy, T. Egan, et al, “Interrogating Alkyl and Arylalkylpolyamino (Bis)Urea and (Bis)Thiourea Isosteres as Potent Antimalarial Chemotypes against Multiple Lifecycle Forms of Plasmodium falciparum Parasites,” Bioorganic & Medicinal Chemistry 23, no. 16 (2015): 5131–43.
   PubMed Web of Science ®Google Scholar
• S. K. Sharma, Y. Wu, N. Steinbergs, M. L. Crowley, A. S. Hanson, R. A. Casero, and P. M. Woster, “(Bis)Urea and (Bis)Thiourea Inhibitors of Lysine-Specific Demethylase 1 as Epigenetic Modulators,” Journal of Medicinal Chemistry 53, no. 14 (2010): 5197–212.
   PubMed Web of Science ®Google Scholar
• S. R. Devineni, M. Golla, N. R. Chamarthi, B. Meriga, M. S. Saddala, and U. R. Asupathri, “2-Amino-2,3-Dihydro-1H-2λ5-[1,3,2]Diazaphospholo[4,5-b]Pyridin-2-One-Based Urea and Thiourea Derivatives: synthesis, Molecular Docking Study, and Evaluation of anti-Inflammatory and Antimicrobial Activities,” Medicinal Chemistry Research 25, no. 4 (2016): 751–68.
   Web of Science ®Google Scholar
• M. R. Mannam, S. R. Devineni, C. M. Pavuluri, R. Chamarthi, and R. S. P. Kottapalli, “Urea and Thiourea Derivatives of 3-(Trifluoromethyl)-5,6,7,8-Tetrahydro-[1, 2, 4]Triazolo[4,3-a]Pyrazine: synthesis, Characterization, Antimicrobial Activity, and Docking Studies,” Phosphorus Sulfur Silicon and Related Elements 194, no. 9 (2019): 922–32.
   Web of Science ®Google Scholar
• T. B. Shaik, S. Chennamsetty, S. R. Devineni, N. R. Shaik, N. D. Mundla, J. P. Rajkumari, and N. R. Chamarthi, “Catalyst-Free Green Synthesis of Urea and Thiourea Derivatives of Tetramethylguanidine (TMG) and Evaluation of Biological Activity,” Bulgarian Chemical Communications 46 (2014): 724–30.
   Google Scholar
• Clinical Laboratory Standards Institute. “Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard — Second Edition,” NCCLS Doc (2002): M27–A2.
   Google Scholar
• CLSI“Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard,” CLSI Document (2015): M07–A10.
   Google Scholar
• S. R. Devineni, M. Golla, T. Basha Shaik, J. Avilala, M. Sudhana Saddala, N. Golla, and N. Raju Chamarthi, “Ethyl Phosphoramidates of Acyclovir: Design, Synthesis, Molecular Docking (HN Protein), and Evaluation of Antiviral and Antioxidant Activities,” Medicinal Chemistry Research 26, no. 5 (2017): 999–1009.
   Web of Science ®Google Scholar
• I. F. F. Benzie, and J. J. Strain, “The Ferric Reducing Ability of Plasma (FRAP) as a Measure of “Antioxidant Power”: the FRAP Assay,” Analytical Biochemistry 239, no. 1 (1996): 70–6.
   PubMed Web of Science ®Google Scholar
• G. M. Morris, R. Huey, W. Lindstrom, M. F. Sanner, R. K. Belew, D. S. Goodsell, and A. J. Olson, “AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility,” Journal of Computational Chemistry 30, no. 16 (2009): 2785–91.
   PubMed Web of Science ®Google Scholar
• E. F. Pettersen, T. D. Goddard, C. C. Huang, G. S. Couch, D. M. Greenblatt, E. C. Meng, and T. E. Ferrin, “UCSF Chimera–A Visualization System for Exploratory Research and Analysis,” Journal of Computational Chemistry 25, no. 13 (2004): 1605–12.
   PubMed Web of Science ®Google Scholar
• G. Vistoli, A. Pedretti, and B. Testa, “Assessing Drug-Likeness-What Are we Missing?,” Drug Discovery Today 13, no. 7–8 (2008): 285–94.
   PubMed Web of Science ®Google Scholar
• Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy, and Paul J. Feeney, “Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings,” Advanced Drug Delivery Reviews 46, no. 1–3 (2001): 3–26.
   PubMed Web of Science ®Google Scholar
• R. Nasab, F. Hassanzadeh, and M. Mansourian, “Synthesis, Antimicrobial Evaluation and Docking Studies of Some Novel Quinazolinone Schiff Base Derivatives,” Research in Pharmaceutical Sciences 13, no. 3 (2018): 213–21.
   PubMed Web of Science ®Google Scholar
• R. T. Sadikot, T. S. Blackwell, J. W. Christman, and A. S. Prince, “Pathogen-Host Interactions in Pseudomonas aeruginosa Pneumonia,” American Journal of Respiratory and Critical Care Medicine 171, no. 11 (2005): 1209–23.
   PubMed Web of Science ®Google Scholar
• Ali Yıldırım, Ahmet Mavi, and Ayşe Aydan Kara, “Determination of Antioxidant and Antimicrobial Activities of Rumex Crispus L. extracts,” Journal of Agricultural and Food Chemistry 49, no. 8 (2001): 4083–9.
   PubMed Web of Science ®Google Scholar
• J. R. Soare, T. C. P. Dinis, A. P. Cunha, and L. Almeida, “Antioxidant Activities of Some Extracts of Thymus Zygis,” Free Radical Research 26, no. 5 (1997): 469–78.
   PubMed Web of Science ®Google Scholar
• J. Baumann, G. Wurm, and F. V. Bruchhausen, “Hemmung Der Prostaglandinsynthetase Durch Flavonoide Und Phenolderivate im Vergleich Mit Deren O2-.–Radikalfanger- Eigenschaften,” Archiv Der Pharmazie 313, no. 4 (1980): 330–7.
   PubMedGoogle Scholar
• P. Heisig, “Inhibitors of Bacterial Topoisomerases: Mechanisms of Action and Resistance and Clinical Aspects,” Planta Medica 67, no. 1 (2001): 3–12.
   PubMed Web of Science ®Google Scholar
• A. Maxwell and D. Lawson, “The ATP-Binding Site of Type II Topoisomerases as a Target for Antibacterial Drugs,” Current Topics in Medicinal Chemistry 3, no. 3 (2003): 283–303.
   PubMed Web of Science ®Google Scholar
• E. L. Zechiedrich, A. B. Khodursky, S. Bachellier, R. Schneider, D. Chen, D. M. J. Lilley, and N. R. Cozzarelli, “Roles of Topoisomerases in Maintaining Steady-State DNA Supercoiling in Escherichia coli,” The Journal of Biological Chemistry 275, no. 11 (2000): 8103–13.
   PubMed Web of Science ®Google Scholar
• N. R. Chamarthi, V. C. Ponne, H. B. Pulluru, J. D. Balija, S. R. Gutala, S. V. Kallimakula, V. Chintha, and R. Wudayagiri, “New Symmetrical Acyclic and Alicyclic Bisurea Derivatives of 4,4’-Methylenebis(Phenyl Isocyanate): Synthesis, Characterization, Bioactivity and Antioxidant Activity Evaluation and Molecular Docking Studies,” Organic Communications 11, no. 2 (2018): 80–97.
   Web of Science ®Google Scholar
• Y. H. Zhao, M. H. Abraham, A. Le, J. Hersey, C. N. Luscombe, G. Beck, B. Sherborne, and I. Cooper, “Rate-Limited Steps of Human Oral Absorption and QSAR Studies,” Pharmaceutical Research 19, no. 10 (2002): 1446–57.
   PubMed Web of Science ®Google Scholar
• G. Walkinshaw, and C. M. Waters, “Neurotoxin-Induced Cell Death in Neuronal PC12 Cells is Mediated by Induction of Apoptosis,” Neuroscience 63, no. 4 (1994): 975–87.
   PubMed Web of Science ®Google Scholar